NGS data analysis market to hit $4.21b by 2032

Thanks to the growing need for personalised healthcare.

The next-generation sequencing (NGS) data analysis market is projected to reach $4.21b by 2032 at a compound annual growth rate of approximately 20%, according to SNS Insider pvt ltd.

The sector’s expansion is attributed to the increasing need for personalised healthcare, lowering sequencing costs, and the rapid growth of genomic research programmes.

Moreover, it is driven by an increasing prevalence of complex genetic diseases, cancer, and infectious diseases.

“Advances in computational biology, big data analytics, and AI-based bioinformatics tools help to further enable faster and more accurate study of vast NGS databases,” the report said.